Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fresenius SE KGaAXSWX:FRE 66 Cyclically Adjusted Price-to-FCF is 23.00 as of Aug. 20, 2026, which is 3% above its 10-year median of 22.38. GuruFocus rates XSWX:FRE with a GF Score™ of 66/100 and a GF Value™ of CHF37.53 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 204 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 57.35% on this metric.
The historical rank and industry rank for Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
XSWX:FRE'
s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 13.4 Med: 22.38 Max: 203.5
Current: 22.08
During the past years, Fresenius SE KGaA's highest Cyclically Adjusted Price-to-FCF was 203.50. The lowest was 13.40. And the median was 22.38.
XSWX:FRE's Cyclically Adjusted Price-to-FCF is ranked worse than 57.35% of 204
companies
in the Healthcare Providers & Services industry
Industry Median: 18.735
vs XSWX:FRE: 22.08
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Fresenius SE KGaA's adjusted free cash flow per share data for the three months ended in Jun. 2026 was CHF0.169. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is CHF1.93 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Fresenius SE KGaA (XSWX:FRE) Cyclically Adjusted Price-to-FCF Explanation
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Fresenius SE KGaA Cyclically Adjusted Price-to-FCF Related Terms
Fresenius SE KGaA Cyclically Adjusted Price-to-FCF Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA Cyclically Adjusted Price-to-FCF Chart
XSWX:FRE vs HCA, THC, DVA: Cyclically Adjusted Price-to-FCF Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF falls into.
Fresenius SE KGaA Cyclically Adjusted Price-to-FCF Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted Price-to-FCF of 23.00 mean?
Fresenius SE KGaA (XSWX:FRE) has a Cyclically Adjusted Price-to-FCF of 23.00 as of Aug. 20, 2026. Cyclically Adjusted Price-to-FCF Ratio is the ratio of share price to a company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fresenius SE KGaA and its competitors. This is near median its historical median of 22.38. Over the past decade, Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF has ranged from 13.40 to 203.50. According to the industry distribution chart, Fresenius SE KGaA ranks #117 out of 204 companies in the Healthcare Providers & Services industry, placing it in the top 57.4%.
Is Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF too high?
Fresenius SE KGaA's current Cyclically Adjusted Price-to-FCF of 23.00 is near median its 10-year median of 22.38. Over the past 10 years, this metric has ranged from a low of 13.40 to a high of 203.50. The Healthcare Providers & Services industry median Cyclically Adjusted Price-to-FCF is 18.74. Fresenius SE KGaA's value of 23.00 is 22.8% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #117 out of 204 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Cyclically Adjusted Price-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #117 out of 204 companies for Cyclically Adjusted Price-to-FCF. This places Fresenius SE KGaA in the lower half of its industry. The industry median Cyclically Adjusted Price-to-FCF is 18.74. Fresenius SE KGaA's value of 23.00 is 22.8% above this benchmark. Historically, Fresenius SE KGaA's own Cyclically Adjusted Price-to-FCF has ranged from 13.40 to 203.50 over the past decade. While the company's 10-year median is 22.38 vs. the industry median of 18.74, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Price-to-FCF for a Healthcare Providers & Services company?
The median Cyclically Adjusted Price-to-FCF among Healthcare Providers & Services companies is 18.74, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted Price-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted Price-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Cyclically Adjusted Price-to-FCF of 23.00 is 22.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Price-to-FCF mean?
A high Cyclically Adjusted Price-to-FCF can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted Price-to-FCF Ratio is the ratio of share price to a company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted Price-to-FCF is 18.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Cyclically Adjusted Price-to-FCF is 23.00, which is near median its own 10-year median of 22.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF37.53, compared to a current price of CHF44.39 — trading 18.3% above its estimated fair value. The current Cyclically Adjusted Price-to-FCF is 23.00, which is near median its 10-year median of 22.38 and 22.8% above the Healthcare Providers & Services industry median of 18.74. Fresenius SE KGaA's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Price-to-FCF calculated?
Cyclically Adjusted Price-to-FCF is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Cyclically Adjusted Price-to-FCF is 23.00 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF44.39 is trading 18.3% above its estimated GF Value™ of CHF37.53.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
Cyclically Adjusted Price-to-FCF: 23.00 (near median its 10-year median of 22.38)
GF Value™: CHF37.53 vs. price of CHF44.39 (18.3% above fair value)
Industry Position: 22.8% above the Healthcare Providers & Services median (#117 of 204)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
66GF Score
Get the complete analysis for XSWX:FRE
Cyclically Adjusted Price-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
